News & Updates

Older patients with cirrhosis who are taking bisphosphonates appear to have a reduced incidence of fractures overall, according to a study.

Red light therapy, sometimes referred to as photobiomodulation therapy or PBMT, has garnered significant interest because of its possible medical advantages, especially in the field of ophthalmology. Low-power red to near-infrared (NIR) light is used in PBMT to activate biological processes.

Once-weekly treatment with HRS9531, a novel dual GLP-1* and GIP** receptor agonist, resulted in substantial reductions in body weight among Chinese patients with obesity, according to a study presented at ADA 2024.

New drug applications approved by US FDA as of 1-15 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Infant factors affecting the microbiome appears to influence the occurrence of juvenile spondyloarthritis (JSpA), suggests a study, noting a link between exclusive breastfeeding and lower odds of JSpA.

Changing your usual eating pattern to one that is focused on longevity can bring substantial increases in life expectancy (LE), suggests a study that involved seven countries. These dietary changes include more whole grains, legumes, and nuts and less red/processed meats, sugars, and sugar-sweetened beverages.

Minimal residual disease (MRD)–negative complete remission (CR) rate at end of induction is significantly higher in adult patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukaemia (ALL) treated with ponatinib vs imatinib combined with reduced-intensity chemotherapy, results of the phase III PhALLCON trial have shown.